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Abstract
Background: Starch is a main source of glucose and energy in the human diet. The extent to which it is
digested in the gastrointestinal tract plays a major role in variations in postprandial blood glucose levels.
Interactions with other biopolymers, such as dairy proteins, during processing can influence both the duration
and extent of this postprandial surge.
Objective: To evaluate the effect of the addition of bovine a-o rb-casein to waxy maize starch on changes in
postprandial blood glucose, insulin, and incretin hormones [glucose-dependent insulinotropic polypeptide
(GIP) and glucagon-like peptide 1 (GLP-1)] in 30 kg pigs used as an animal model for humans.
Design: Gelatinised starch, starch gelatinised with a-casein, and starch gelatinised with b-casein were orally
administered to trained pigs (n  8) at a level of 60 g of available carbohydrate. Pre- and postprandial glucose
measurements were taken every 15 min for the first hour and every 30 min thereafter up to 180 min. Insulin,
GIP, and GLP-1 levels were measured in plasma samples up to 90 min postprandial.
Results: Starch gelatinised with a-casein had a significantly (p B 0.05) lower peak viscosity on pasting and
resulted in significantly lower glucose release at 15, 30, and 90 min postprandial compared to starch
gelatinised with b-casein. During the first 45-min postprandial, the area under the glucose curve (AUC) for
starch gelatinised with a-casein was significantly (p B 0.05) lower than that for starch gelatinised with
b-casein. There was also a significant (p B 0.05) difference at T30 in GIP levels in response to the control
compared to starch gelatinised with a-o rb-casein. Significant (p B 0.05) increases in several free amino acid
concentrations were observed on ingestion of either a-o rb-casein gelatinised with starch at 30 and 90 min
postprandial compared to starch alone. In addition, plasma levels of six individual amino acids were
increased on ingestion of starch gelatinised with a-casein compared to ingestion of starch gelatinised with
b-casein.
Conclusion: The presence of casein fractions (a-o rb-casein) in gelatinised waxy maize starch affects swelling
characteristics, viscosity, and subsequent in vivo digestion as determined by glucose levels in blood
postprandial.
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T
here is increasing interest in the role of carbohy-
drate (CHO) ingestion in the metabolic syndrome
and subsequent health effects relating to glycemia
and type 2 diabetes (1). Ingestion of foods, which result in
a decreased rate of carbohydrate absorption, leads to a
more controlled release of glucose into the bloodstream.
These foods have a lower glycemic index (GI) value. The
GI system ranks carbohydrate foods based on their
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are associated with a rapid rise in both glucose and
insulin in blood after consumption (3). Hyperinsulinemia
can reduce insulin efficiency via downregulation of
insulin receptors, resulting in insulin resistance (4) which,
in addition to impaired pancreatic b-cell function, is a
risk factor for type II diabetes (5). Previous studies have
reported on the benefits of low GI diets in relation to the
metabolic syndrome, i.e. improved blood glucose control
and glucose tolerance (6), improvements in insulin
sensitivity (7), and a reduction of insulin resistance (8).
Upon ingestion, nutrients stimulate the secretion of
various hormones and peptides by specialised enteroen-
docrine cells in the gastrointestinal tract. This informs the
gut and pancreas of the impending arrival of glucose and
ensures that insulin is produced and secreted by pancrea-
tic b-cells to maintain glucose homeostasis. This signal-
ling is primarily achieved by the incretin hormones,
glucagon-like peptide 1 (GLP-1) and glucose-dependent
insulinotropic polypeptide (GIP), secreted by the gut,
which act to stimulate insulin release and suppress
glucagon (9). These hormones primarily respond to
carbohydrate and fat ingestion but can also respond to
proteins and amino acids (10).
It is well established that proteins within a defined food
matrix can affect the rate at which carbohydrates are
metabolised in vivo (1114). The authors hypothesise that
the addition of dairy protein fractions, a-o rb-casein, to
waxy maize starch will have a postprandial glucose
lowering effect. Previous results from rheological, micro-
scopical, and simulated gastrointestinal digestion studies
showed a restriction in granule swelling and decreased
maltose and glucose levels when starch is gelatinised with
casein fractions. These results were not observed when
starch was gelatinised with whey fractions (a-lactalbumin
and b-lactoglobulin) (15).
The authors used the pig as an animal model for
humans due to its omnivore status and its similarity to
humans in digestive physiology, hormonal response,
metabolism, and organ size (16, 17). The present study
investigates the effect of adding enriched a-o rb-casein
fractions to gelatinised waxy maize starch on postpran-
dial blood levels of glucose, insulin, and incretin hor-
mones in 30 kg pigs.
Materials and methods
The protein enriched a- and b-casein fractions were
sourced from Kerry Ingredients (Listowel Co., Kerry).
The protein content of the a-casein was 84.1% and the
b-casein 85.6%, as determined by Kjeldahl nitrogen
6.25 (18). Casein fractions (10% w/w) on a protein
basis were made up by dissolving the powders in Milli-Q
water at room temperature, with the aid of an overhead
stirrer and stored overnight at 48C to ensure complete
hydration.
Waxy maize starch (trade name Amioca Powder TF)
was kindly provided by National Starch (Manchester,
UK). All trial samples (starch alone or starch gelatinised
with a-o rb-casein) were gelatinised by heating to 908C
using in-direct steam heating (operating steam pressure of
1 bar) and held for 6 min to ensure complete gelatinisa-
tion, then cooled to 208C in a Stephen cooker (closed
system) UMM/SK5 (Stephan U Sohne GMBH  Co.,
Hameln, Germany) using a mixing baffle operated at
100% capacity and the main motor at 50% capacity.
Sample preparation was staggered each day so that each
sample was fed to the pigs immediately after the pasting
process to reduce retrogradation of the starch.
Pasting behaviour
All samples were pasted as a model system using the same
composition as the investigated samples on an AR-G2
Rheometer (TA Instruments, Crawley, UK) fitted with a
starch pasting cell (sample size 28 g). The internal
diameter of the cell was 36 mm and the diameter of the
rotor used was 32 mm with a geometry gap of 550 mm.
A thermal cycle was used to provide conditions for
gelatinisation, pasting, and subsequent molecular rear-
rangement on cooling. All samples were tempered at
358C, heated from 358Ct o9 5 8C at a ramp rate of 14.58C
/min, held for 6 min, subsequently cooled from 958Ct o
358C at a ramp rate of 298C /min, and finally held for
10 min at 358C using a shear rate of 16.78 1/s.
Experimental design
A progeny of Large White  Landrace crossbred pigs
(n 8) (reared in the Pig Development Unit) with abody
weight of 30 kg (92) were trained 1 week before trial
commencement to eat 10% w/w (600 g) gelatinised starch
samples within a 10-min period. The control sample
contained 60 g w/w (60 g available CHO) of waxy maize
starch in 540 g of water. The starch and protein samples
contained 60 g w/w of starch, 71.3 g of a-casein, and
468.8 g of water or 60 g w/w of starch, 70.1 g of b-casein,
and 469.9 g of water. (Note: all starch-protein samples
were made up on protein basis.) There were no additional
ingredients in the sample, i.e. fat, other carbohydrates, or
minerals. Additional constituents of a typical pig diet add
caloric value and would have an effect on glucose and
insulin levels. On completion of training, the pigs were
catheterised in the lateral ear vein for blood sampling.
Prior to commencement of sampling, a 24-h resting
period allowed clearance of the anaesthetics from the
body. The pigs were fasted from 16.00 h the previous day
after there afternoon meal. Nine pigs were trained for
the trial; however, due to problems with one catether,
one pig was removed from the trial postcatheterisation.
The concentrations of the three semisolid gelatinised
foods ingested on a component level were (i) 10% starch
(control); (ii) 10% starch  10% a-casein; and (iii) 10%
Anthony P. Kett et al.
2
(page number not for citation purpose)
Citation: Food & Nutrition Research 2012, 56: 7989 - DOI: 10.3402/fnr.v56i0.7989starch  10% b-casein. The protein and lipid concentra-
tions naturally present in waxy maize starch were not
accounted for as these concentrations are minimal (19).
The eight pigs were fed 600 g as a single meal of each
gelatinised semisolid food containing 60 g of available
CHO. Replicates for each sample were staggered across
3 days to exclude sampling day as a variable. All
experiments complied with EU Council Directive
91/630/EEC, which lays down minimum standards for
the protection of pigs, and EU Council Directive 98/58/
EC, which concerns the protection of animals kept for
farming purposes. A licence to perform experiments
on live animals under the cruelty of animals act,
1876 regulations 2002 and 2005, was obtained before
commencing this work.
Catheterisation
Insertion of catheters was performed on anaesthetised
pigs according to Niiyama et al. (20) with the following
modifications: pigs were anaesthetised with detomidine
(0.13 mg/kg body weight), butorphanol (0.26 mg/kg), and
ketamine (5 mg/kg). Prior to anaesthesia, the pigs were
fasted for 24 h and the weight of the pigs recorded before
administration of the drugs to ensure proper dosage. The
lateral auricular vein was selected for catheterisation
because of its smooth trajectory. The ear was occluded
with a rubber band (at the base of the ear) to dilate the
vein and removed after the venous access catheter was in
place. Once the pig was under anaesthesia (after 15 min
of drug administration), the ear was shaved and cleaned
with 70% ethanol, and the vein was dilated by hot water
application to the ear. Catheterisation was performed
using a 3-FR 55-cm peripherally inserted central catheter
(PICC) with trimmable placement wire (Arrow Interna-
tional Inc. Reading, PA, US) comprised of a venous
access cannula (VAC) and 17-G peel away catheter over a
19-G needle. Only 40 cm was inserted and the tip of the
catheter trimmed off. Venous access was obtained by
inserting the VAC in the ear vein and removing the
needle. The PICC was then inserted through the 17-G
peel away catheter. When the insertion was complete, the
guide wire was removed and the correct positioning
assessed by sampling 23 mL of blood. After insertion,
the peel away catheter was removed and the PICC flushed
with isotonic saline solution. Pressure was applied at the
insertion point to prevent haemorrhaging. The hub of the
PICC was secured to the skin by suture with non-
resorbable wire and an extension added to minimise the
pigs’ manipulation during blood sampling. Several suture
points were placed along the neck and back to hold the
extension in place. Air was completely removed and
the whole system flushed with isotonic saline and
primed with Heparin solution (0.01 units/L diluted to
2%). The insertion point was disinfected thoroughly with
70% ethanol and covered with Leukoplast to prevent
infection. After the procedure, the pigs were placed in a
warm environment in single pens and checked every 30
min until full recovery, usually within 2 h. Every pig was
examined at least 3 times daily to ensure that the catheter
was in position and to detect any associated health
problems early.
Glucose analysis
Blood glucose was measured using a Glucomen Visio†
glucometer (A. Menarini Diagnostics, Firenze, Italy) as
per the manufacturer’s instructions. The glucometer was
calibrated every morning before sampling using the
Glucomen Visio control solution provided. The calibra-
tion region of the glucometer fell between 4.7 and 6.4
mmol/L. The sampling times for glucose were T0, T15,
T30, T45, T60, T90, T120, T150, and T180 min.
Blood sampling
Blood samples were collected at 3 time point intervals:
T0, T30 and T90 min, into prechilled vacutainers
containing 18.0 mg K2EDTA (BD Biosciences, Oxford-
shire, England). For GLP-1 analysis at T0 and T90,
Dipeptidyl peptidase IV (DPPIV) inhibitor (Millipore,
Ltd., Watford, UK) was added within 30 s of collection,
at a concentration of 0.01 mL/L of blood. Tubes were
inverted several times to ensure a homogenous mix.
Blood samples were kept on ice following collection and
then centrifuged at 2500g for 15 min at 48C within 1 h of
collection. Plasma was obtained after centrifugation and
stored at 808C until analyses.
Incretin hormones and insulin assays
Using ELISA commercial kits, plasma concentrations of
active GLP-1 [GLP-1 (active) ELISA Kit, Millipore],
total GIP [Rat/Mouse GIP (total) ELISA Kit, Millipore],
and insulin (Human Insulin ELISA Kit, Millipore) were
measured. The sensitivity limits of the ELISA kits were
2.0 nU/L for intact insulin, 8.0 fg/L for total (active and
inactive) GIP, and 2.0 fmol/L for active GLP-1. Each
plasma sample was assayed in triplicate. The concentra-
tions of insulin, GIP, and GLP-1 were derived by
interpolation from a reference curve generated in each
individual assay with reference standards of known
concentrations of insulin, GIP, and GLP-1, respectively.
Amino acid composition
Plasma samples were deproteinised by mixing equal
volumes of 24% (w/v) tri-chloroacetic acid (TCA) and
sample, allowed to stand for 10 min and centrifuged at
14,400g for 10 min. Supernatants were removed and
diluted with 200 mmol/L sodium citrate buffer, pH 2.2, to
give approximately 250 nmol of each amino acid residue.
Samples were then diluted 1 in 2 with the internal
standard, norleucine, to give a final concentration of
0.125 nmol/L. Amino acids were quantified using a Jeol
Postprandial effects of a-o rb-casein on waxy maize starch
Citation: Food & Nutrition Research 2012, 56: 7989 - DOI: 10.3402/fnr.v56i0.7989 3
(page number not for citation purpose)JLC-500/V amino acid analyser (Jeol, Ltd., Garden city,
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 high performance
cation exchange column.
Statistical analysis
Data sets were analysed using the mixed models proce-
dure in SAS (Statistical Analysis Systems Institute
Incorporated, NC) for an incomplete latin square design.
The pig was the experimental unit. The model included
the effects for treatment, time of sampling, and the
interaction effect between treatment and time of sam-
pling. Animal weight was used as a covariant in the
model. Animal was fitted as a repeated effect with
compound symmetry (Co) variance structure assumed
among records within animal. Treatment effect at parti-
cular times of sampling was determined using the slice
statement in SAS. The results were presented as least
square means 9 SEM. Means separation was performed
using the TukeyKramer test.
Results
Pasting behaviour
The five stages of the gelatinisation/pasting process are
outlined in Fig. 1. Significant (p B 0.05) differences were
observed between samples for each stage throughout
pasting (Table 1). Significantly higher viscosity values
were observed throughout pasting for all samples
containing 10% starch gelatinised with 10% b-casein
(Table 1) while 10% starch gelatinised with 10% a-casein
resulted in a significantly lower peak viscosity (1.7 Pa.s)
compared to 10% starch alone (3.2 Pa.s) or 10% starch
gelatinised with 10% b-casein (4.6 Pa.s). Starch gelati-
nised with 10% a-casein had a significantly higher on-set
pasting temperature (74.78C) compared to 10% starch
alone (68.48C) or 10% starch gelatinised with 10%
b-casein (64.48C). The final paste viscosity increased in
the following order: 10% starch alone (1.7 Pa.s),
10% starch gelatinised with 10% a-casein (4.8 Pa.s), and
10% starch gelatinised with 10% b-casein (7.6 Pa.s).
Glucose levels
The pre- and postprandial blood glucose concentrations
in response to (i) 10% starch, (ii) 10% starch gelatinised
with 10% a-casein, or (iii) 10% starch gelatinised with
10% b-casein over 3 h are illustrated in Fig. 2. A rapid
increase in glucose concentration was observed 15 min
postprandial in response to gelatinised 10% starch, rising
to a peak of 5.1 mmol/L. After the initial increase, an
additional peak of 4.9 mmol/L was observed at T90 with
a subsequent decrease to 4.1 mmol/L at 180 min
postprandial. Ingestion of 10% starch gelatinised with
10% b-casein also resulted in a rise in blood glucose
concentration within 15 to 30 min, with a peak value of
5.4 mmol/L. A second peak in glucose concentration
was observed at T90 (5.2 mmol/L) with a decline to
3.6 mmol/L at T180 postprandial. In contrast, ingestion
of 10% starch gelatinised with 10% a-casein resulted in a
more gradual increase in blood glucose concentration
reaching a peak of 4.6 mmol/L at T30. From T60 to
T180, postprandial glucose concentrations decreased to
3.6 mmol/L. Starch gelatinised with a-casein resulted in
significantly (pB0.05) lower glucose release at 15, 30, and
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
048 1 2 1 6 2 0
Time (min)
V
i
s
c
o
s
i
t
y
 
(
P
a
.
s
)
0
10
20
30
40
50
60
70
80
90
100
T
e
m
p
e
r
a
t
u
r
e
 
(
°
C
)
A
B
C
DE
Fig. 1. Gelatinisation proﬁle of 10% starch ( ), 10% starch
 10% a-casein ( ), and 10% starch  10% b-casein ( );
(x) represents temperature proﬁle. Point A on the curve
represents the on-set stage of pasting, B represents peak
viscosity on heating, C represents viscosity at end of heating,
D represents viscosity at end of cooling, and E represents the
ﬁnal viscosity of the paste.
Table 1. Pasting viscosities of treatments throughout gelatinisation.
n
On-set pasting
temp (8C) (a)
Peak viscosity on
heating (Pa.s) (b)
End of heating
(Pa.s) (c)
End of cooling
(Pa.s) (d)
Final viscosity
(Pa.s) (e)
10% starch 3 68.4
b 3.2
b 1.2
b 2.1
c 1.7
c
10% starch  10% a-casein 3 74.7
a 1.7
c 0.5
c 4.3
b 4.8
b
10% starch  10% b-casein 3 64.4 4.6
a 1.7
a 6.7
a 7.6
a
df
* 88 8 8 8
acValues within column with different lowercase letters are significantly different (p B 0.05; Fishers’ test).
*degrees of freedom.
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b-casein.
AUC values for the initial rise (T0T45) in blood
glucose concentrations were 204, 194, and 226 mmol/
(L min) on ingestion of 10% starch, 10% starch gelati-
nised with 10% a-casein, and 10% starch gelatinised
with 10% b-casein, respectively. A significant difference
(p B 0.05) was observed in AUC (T0T45) between the
10% starch gelatinised with 10% b-casein and the 10%
starch gelatinised with 10% a-casein samples, with the
latter being significantly lower. The second peak (T60
T120) resulted in AUC values of 141, 129, and 149 mmol/
(L min) for 10% starch, 10% starch gelatinised with 10%
a-casein, and 10% starch gelatinised with 10% b-casein
respectively and (T0T180) AUC values of 808, 752, and
846 mmol/(L min), respectively.
GLP-1 analysis
There were no significant differences in postprandial
plasma GLP-1 concentrations following ingestion of (i)
10% starch, (ii) 10% starch gelatinised with 10% a-casein,
or (iii) 10% starch gelatinised with 10% b-casein (Table 2).
Preprandial concentrations of plasma GLP-1 ranged
from 6.7 to 7.0 pmol/L. At T90, these levels increased
between 7.0 and 7.9 pmol/L.
GIP analysis
Postprandial GIP concentrations in plasma over 90 min
in response to (i) 10% starch, (ii) 10% starch gelatinised
with 10% a-casein, and (iii) 10% starch gelatinised with
10% b-casein are detailed in Fig. 3A. Preprandial plasma
concentrations of GIP was 151 (SE39) fg/L. The GIP
concentration increased to 1,509 (SE117) fg/L at T30
and decreased to 959 (SE135) fg/L at T90 in response
to 10% starch alone. Ingestion of 10% starch gelatinised
with 10% a-casein resulted in plasma GIP concentrations
at T0, T30, and T90 of 155 (SE24), 2,109 (SE180),
and 1,348 (SE149) fg/L, respectively. There was a
significant (pB0.05) difference at T30 in GIP levels in
response to the control compared to starch gelatinised
with a-o rb-casein.
Insulin analysis
Postprandial plasma concentrations of insulin in re-
sponse to (i) 10% starch, (ii) 10% starch gelatinised
with 10% a-casein, and (iii) 10% starch gelatinised with
10% b-casein are detailed in Fig. 3B. Ingestion of 10%
starch resulted in a rise from 21 (SE3) nU/L to 111
(SE21) nU/L in 30 min. This was followed by a decline
to 38 (SE8) nU/L at T90. Ingestion of 10% starch
gelatinised with 10% b-casein resulted in a rise from 18
(SE2) nU/L to 151 (SE25) nU/L within 30 min and
decreased to 55 (SE9) nU/L at T90. Ingestion of 10%
starch gelatinised with 10% a-casein resulted in a rise
from 20 (SE2) nU/L to 138 (SE23) nU/L within 30
min, decreasing to 74 (SE13) nU/L at T90. Postpran-
dial insulin levels at T30 tended (pB0.1) to be higher
for starch gelatinised with b-casein compared to 10%
starch and at T90 tended (pB0.1) to be higher for
10% starch gelatinised with 10% a-casein compared
to 10% starch. Plasma levels for both GIP and insulin
peaked at the same time point (T30).
Amino acid composition
Total amino acid concentration in plasma (Fig. 3C)
decreased on ingestion of 10% starch alone from a T0
concentration of 1,213 pmol/L to a T90 concentration of
887 pmol/L. There was a significant (pB0.05) increase in
plasma amino acid concentration at T30 and T90
postprandial in response to 10% starch gelatinised with
10% a-casein and 10% starch gelatinised with 10%
b-casein compared to T0 levels. Not surprisingly, there
was a significant (pB0.05) increase in plasma concentra-
tions of individual free amino acids, postprandial in
response to 10% starch gelatinised with 10% a-casein and
10% starch gelatinised with 10% b-casein at T30 and T90
(Figs 4B and 4C) compared to basal levels. Exceptions to
this were levels of glycine, cysteine, and asparagine.
Moreover, there was a significant (pB0.05) increase in
T90 plasma levels of leucine, phenylalanine, lysine,
tyrosine, histidine, and arginine postingestion of 10%
starch gelatinised with 10% a-casein compared to
10% starch gelatinised with 10% b-casein (Fig. 4C).
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Fig. 2. Postprandial blood glucose concentrations following
ingestion of 10% starch ( ), 10% starch  10% a-casein
( ) and 10% starch  10% b-casein ( ).
(a-b)Values
with different lowercase letters are signiﬁcantly different
(p B 0.05).
Table 2. Plasma GLP-1 concentrations (pmol/L) at T0 and T90
following ingestion of 10% starch, 10% starch  10% a-casein, and
10% starch  10% b-casein.
10% starch
(pmol/L)
10% starch 10%
a-casein (pmol/L)
10% starch 10%
b-casein (pmol/L)
T0 7.01 6.78 6.65
T90 7.87 7.34 7.04
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Ingestion of starch gelatinised with a-casein resulted in a
lower postprandial glucose peak, lower glucose levels
over 120 min, and increased levels of several free amino
acids than ingestion of starch gelatinised with b-casein.
The difference in blood glucose levels may be explained
by the lower peak viscosity of starch-a-casein compared
to that of the starch-b-casein equivalent. Lower peak
viscosity may be indicative of reduced granule swelling.
Previous work by Kett et al. showed that the swelling
characteristics of starchprotein mixtures were concen-
tration dependent (15). The starchprotein concentration
[compared to previous studies at 5% (15)] in this study,
i.e. 10%, appeared to result in more extensive restriction
to swelling in the starcha-casein mixture. During
heating, starch granules absorb water and increase in
size resulting in a concomitant increase in viscosity (21).
We postulate that granule restriction specific to the starch
and a-casein mixture may be due to (i) competition
between the starch and a-casein for available water in the
mixture or (ii) association of a-casein with the surface
proteins/lipids of the starch granules protecting granular
structure (22). Protection of starch granules, resulting in
increased granular structure, may have resulted in re-
duced digestion by pancreatic a-amylase activity and
delayed glucose release into the blood. Several studies
have demonstrated granule restriction of starch in the
presence of various polymers including proteins (23, 24).
In addition, water competition has been reported in
heated solutions of waxy rice starch and sodium caseinate
(25). Studies performed by the authorswould suggest that
reduced granular swelling has a role to play in inhibiting
enzymatic hydrolysis, delaying subsequent breakdown of
the starch. Confocal and light microscopy indicated that
waxy maize starch gelatinised in the presence of a-o r
b-casein resulted in a significant reduction in granular
swelling compared to starch gelatinised alone (15).
Studies by Manders et al. (26) showed that, in healthy
and diabetic patients, ingestion of a carbohydrate (50:50
glucosemaltodextrin mixture) and casein hydrolysate
amino acid mixture lowers plasma glucose concentration
compared to ingestion of carbohydrate alone. Previous
work by van Loon et al. (27) with drinks containing
CHO (50:50 glucosemaltodextrin mixture) and three
different protein hydrolysates (i.e. whey, wheat, and
casein) reported that ingestion of the CHOcasein
hydrolysate drink resulted in the lowest blood glucose
levels 30 min postprandial.
Although the plasma levels of total amino acids did
not differ between starchcasein samples, significant
differences at T90 in six (leucine, phenylalanine, lysine,
tyrosine, histidine, and arginine) individual amino acids
postprandial in response to starch gelatinised with
a-casein compared to starch gelatinised with b casein
may be due to differences in (i) molecular state (28), (ii)
hydrophobicity (29, 30), (iii) amino acid sequence and
composition (31), and (iv) serine phosphate groups (32)
of the a- and b-casein proteins. Although as1-casein
and b-casein are 31% homologous, as1-casein consists
of 199 amino acid residues (GenBank GI:30794348)
whereas b-casein is composed of 209 amino acid residues
(GenBank GI:162931) (29). In addition, b-casein has less
phosphate groups than a-casein. In acidic conditions,
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Fig. 3. (A) Plasma GIP concentrations following ingestion
of 10% starch, 10% starch  10% a-casein, and 10% starch
 10% b-casein. Preprandial GIP concentrations [horizon-
tal], 30 min postprandial [slanted], and 90 min postprandial
[vertical]. (B) Insulin concentrations (in plasma) following
ingestion of 10% starch, 10% starch  10% a-casein, and
10% starch  10% b-casein. Preprandial insulin concentra-
tions [horizontal], 30 min postprandial [slanted], and 90 min
postprandial [vertical]. (C) Total amino acid levels of 10%
starch, 10% starch  10% a-casein, and 10% starch  10%
b-casein postprandial at T30 (slanted line) and T90 (vertical
line).
(a-b)Values with different lowercase letters are signiﬁ-
cantly different from each other (p B 0.05).
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casein occurs, reducing the size of protein precipitates,
thus facilitating peptic digestion. Therefore, b-casein with
its lower degree of phosphorylation is more susceptible to
peptic hydrolysis (33). Evidence of this susceptibility can
be seen in Fig. 3C whereby the percentage increase (from
T0T180) in total free amino acids was statistically higher
for the starchb-casein mixture compared to the starch
a-casein mixture. Assuming that the postprandial levels
of the significant six amino acids were primarily as a
result of the dietary source, ingestion of b-casein within
the starch-b-casein mixture resulted in a reduction in the
plasma levels of these amino acids after 90 min, which
may imply that the starchb-casein mixture was absorbed
from the blood at a faster rate than starcha-casein
equivalents. Of the six amino acids that were significantly
different, five are essential amino acids. Adibi et al.
reported that essential amino acids were absorbed more
rapidly within a mixture of amino acids compared to the
non-essential amino acids (34).
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Fig. 4. (A) Concentrations of free amino acids in plasma preprandial (T0) of 10% starch ( ), 10% starch  10% a-casein
( ), and 10% starch  10% b-casein ( ). (B) Concentrations of free amino acids in plasma postprandial (T30) of 10% starch
( ), 10% starch  10% a-casein ( ), and 10% starch  10% b-casein ( ).
(a-b)Values with different lowercase letters are
signiﬁcantly different from each other (p B 0.05). (C) Concentrations of free amino acids in plasma postprandial (T90) of 10%
starch ( ), 10% starch  10% a-casein ( ), and 10% starch  10% b-casein ( ).
(a,b,c)Values with different lowercase letters are
signiﬁcantly different from each other (p B 0.05).
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(page number not for citation purpose)The insulinotropic amino acids, arginine, leucine, and
phenylalanine (35, 36), were significantly (p B 0.05)
higher in plasma 90 min postprandial in response to
starch gelatinised with a-casein compared to starch
gelatinised with b-casein. van Loon et al. (27) showed
that these three amino acids promote insulin production
when orally administered with carbohydrate. There was a
significant difference at T30 in GIP levels in response to
the control compared to starch gelatinised with a-o r
b-casein. Although there was no significant difference in
plasma insulin levels between starch and a-o rb-casein,
there was an observed tendency (p B 0.1) for an increase
in plasma insulin levels 90 min postprandial in response
to starch gelatinised with a-casein albeit compared to
starch alone.
Not surprisingly the addition of casein to starch
resulted in higher levels of free amino acids in the
peripheral blood within 30 min compared to starch alone.
Nilsson et al. (37) reported that peak amino acid levels in
humans for milk proteins occurred 3045 min postpran-
dial, indicating that milk proteins are highly digestible
and result in a rapid release of free amino acids into
peripheral blood.
Conclusions
This study demonstrates that individual protein fractions
can affect swelling characteristics, viscosity, and subse-
quent digestion of waxy maize starch. The presence of
10% a-casein during gelatinisation of the starch resulted
in a significantly lower peak glucose concentration during
subsequent digestion in an in vivo pig model compared to
10% b-casein. The difference in glucose release could be
attributed to (i) restricted granule swelling during gelati-
nisation and/or (ii) differences in viscosity restricting
a-amylase activity during digestion. In addition, plasma
levels of six individual amino acids were increased
following ingestion of starch gelatinised with a-casein
compared to ingestion of starch gelatinised with b-casein.
These findings suggest that the type of protein used in
starch based food systems may influence the ability of the
food to modulate glycemia. This is an important con-
sideration in the design of foods with positive health
benefits.
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